During the past decade, Cleveland Clinic Florida conducted 187 clinical trials. In the 10-year time frame, 187 clinical trials started and 105 clinical trials were completed, i.e. on average, 56.1% percent of trials that started reached the finish line to date. In the past 5 years, 72 clinical trials started and 72 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Florida" #1 sponsor was "The Cleveland Clinic" with 33 trials, followed by "National Cancer Institute (NCI)" with 30 trials sponsored, "United Therapeutics" with 15 trials sponsored, "SWOG Cancer Research Network" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 193 different institutions and companies that sponsored additional 137 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Florida" #1 collaborator was "National Cancer Institute (NCI)" with 37 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 116 different institutions and companies that were collaborators in the rest 101 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Florida" are "Pulmonary Arterial Hypertension" (25 trials), "Pulmonary Hypertension" (12 trials), "Breast Cancer" (8 trials), "Crohn's Disease" (8 trials) and "Breast Adenocarcinoma" (5 trials). Many other conditions were trialed in "Cleveland Clinic Florida" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Florida" are "Drug" (185 trials), "Other" (74 trials), "Biological" (43 trials), "Device" (41 trials) and "Procedure" (27 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (51 trials), "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (13 trials), "Cisplatin" (9 trials) and "Nivolumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Florida" are 255 trials for "All" genders, 34 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 116 active trials in "Cleveland Clinic Florida". 2 are not yet recruiting, 55 are recruiting, 56 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 122 completed trials in Cleveland Clinic Florida, 2 suspended trials, and 40 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Florida, 8 "Phase 1" clinical trials were conducted, 66 "Phase 2" clinical trials and 131 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 51 trials that are defined as “Not Applicable".